Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP) | MicrobiomeTrials← Back to trialsNCT03975153
Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2019-10-03Est. Completion: 2022-08-11
Enrollment target: 15 participants Locations- Oregon Health and Science University, Portland, Oregon, United States
Other microbiome trials you might be interested in
Pityriasis Rubra Pilaris
The purpose of this study is to evaluate the safety and effectiveness of Deucravacitinib (BMS-986165) in Pityriasis Rubr…
Scottsdale, United StatesCompleted Sep 2, 2025
Pityriasis Rubra Pilaris
The purpose of this study is to valuate the clinical efficacy of Bimzelx therapy in adults with Pityriasis Rubra Pilaris…
Jacksonville, United StatesEst. completion Aug 1, 2027